Document is current
Any future updates will be listed below
-
Authors
Makiyama, Junya https://orcid.org/0000-0003-0883-2920
Ohno, Nobuhiro
Jimbo, Koji
Kawamata, Toyotaka
Yokoyama, Kazuaki
Konuma, Takaaki
Kato, Seiko
Takemura, Tomonari
Ito, Ayumu
Tanaka, Takashi
Inamoto, Yoshihiro
Fuji, Shigeo
Imai, Yoichi
Takahashi, Satoshi
Nannya, Yasuhito
Tojo, Arinobu
Fukuda, Takahiro
Uchimaru, Kaoru
- License Information
-
More Information
Article History
Received: 15 March 2025
Revised: 19 August 2025
Accepted: 21 August 2025
First Online: 2 September 2025
Declarations
:
: JM reports consulting fees from Daiichi Sankyo, Janssen Pharmaceutical, and Takeda Pharmaceutical, honoraria from AbbVie GK, AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Janssen Pharmaceutical, Kyowa Kirin, Meiji Seika Pharma, Nippon Shinyaku, Ono Pharmaceutical, Otsuka Pharmaceutical, Sanofi, SymBio Pharmaceutical, and Takeda Pharmaceutical, and support for attending meeting from Takeda Janssen Pharmaceutical. KJ reports honoraria from Daiichi Sankyo and Meiji Seika Pharma. T. Takemura reports honoraria from Amgen, Astellas Pharma, Chugai Pharmaceutical, Kyowa Kirin, Nippon Shinyaku. Y. Inamoto is a lead reviewer of the International Journal of Hematology. Y. Inamoto reports honoraria from Novartis, Janssen Pharmaceutical, and Meiji Seika Pharma. Y. Imai reports honoraria from Celgene/Bristol-Myers Squibb, Johnson & Johnson, Sanofi, and Takeda Pharmaceutical. All the remaining authors declare that they have no conflict of interest.
